[HTML] lww.com

[HTML][HTML] Investigation of clinical predictors of survival in idiopathic pulmonary fibrosis patients: a cohort study in Taiwan

CM Tseng, MY Chen, CY Kao… - Journal of the Chinese …, 2022 - journals.lww.com
Background: Two antifibrotic medications, pirfenidone and nintedanib, have been approved
as treatments for idiopathic pulmonary fibrosis (IPF)—a life-threatening interstitial lung …
被引用次数：2 相关文章

Investigation of clinical predictors of survival in idiopathic pulmonary fibrosis patients: A cohort study in Taiwan

CM Tseng, MY Chen, CY Kao… - Journal of the Chinese …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Two antifibrotic medications, pirfenidone and nintedanib, have been approved
as treatments for idiopathic pulmonary fibrosis (IPF)-a life-threatening interstitial lung …

Investigation of clinical predictors of survival in idiopathic pulmonary fibrosis patients: A cohort study in Taiwan.

CM Tseng, MY Chen, CY Kao… - Journal of the Chinese …, 2022 - europepmc.org
Background Two antifibrotic medications, pirfenidone and nintedanib, have been approved
as treatments for idiopathic pulmonary fibrosis (IPF)-a life-threatening interstitial lung …